天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

返回ChemicalBook首頁>CAS數(shù)據(jù)庫列表>66515-29-5

66515-29-5

中文名稱 MSOP
英文名稱 MSOP
CAS 66515-29-5
分子式 C4H10NO6P
分子量 199.1
MOL 文件 66515-29-5.mol
66515-29-5 結(jié)構(gòu)式 66515-29-5 結(jié)構(gòu)式

基本信息

中文別名
2-甲基-O-磷酸絲氨酸
英文別名
MSOP
2-Methyl-O- phosphonoserine
Serine, 2-methyl-O-phosphono-
(RS)-α-Methylserine-O-phosphate
(R,S)-a-Methylserine-O-phosphate
(RS)-ALPHA-METHYLSERINE-O-PHOSPHATE

物理化學(xué)性質(zhì)

沸點454.0±55.0 °C(Predicted)
密度1.681±0.06 g/cm3(Predicted)
儲存條件Store at RT
溶解度在水中的溶解度為性3mg/mL,澄清(加熱)
酸度系數(shù)(pKa)1.66±0.10(Predicted)
形態(tài)粉末
顏色白色至米色
水溶解性溶于水至100mM

安全數(shù)據(jù)

危險性符號(GHS)GHS hazard pictograms
GHS06
警示詞危險
危險性描述H301
防范說明P301+P310
危險品標志T
危險類別碼25
安全說明45
危險品運輸編號UN 2811 6.1 / PGIII
WGK Germany3

常見問題列表

生物活性
MSOP 是第三組代謝性谷氨酸受體的選擇性拮抗劑,其對 L-AP4 敏感突觸前代謝性谷氨酸受體的 KD 值為 51 μM。
靶點

K D : 51 μM (L-AP4-sensitive presynaptic mGluR).

體外研究

In the presence of 200 μM MSOP, a rightward parallel shift of the dose-response curve to L-AP4 is observed, with an apparent K D calculated as 51±6 μM (n=3). MSOP is shown to be selective for the L-APC sensitive presynaptic mGluR, the apparent K D for the interaction of MSOP with the (1S, 3S)-ACPD sensitive receptor calculated as greater than 700 μM (n=3).

體內(nèi)研究

It is found that TBOA-induced antinociceptive effects are significantly blocked by intrathecal co-administration of MSOP (second phase of formalin model: F 3,16 =30.96, P<0.001; CFA model: F 3,16 =30.77, P<0.001). As expected, intrathecal TBOA (10 μg) reduces the number of formalin-induced flinches and shakes by 47% of the value in the saline-treated group in the second phase (P<0.001) and blocked the CFA-induced decrease in ipsilateral paw withdrawal latency by 60% of the value in the saline-treated group (P=0.01). The number of formalin-induced flinches in the second phase in the group treated with MSOP and TBOA is increased by 56% (P=0.04) of the value in the TBOA-treated group. CFA-induced paw withdrawal latency in the group treated with MSOP and TBOA is decreased by 86% (P=0.03) of the value in the TBOA-treated group.

"66515-29-5" 相關(guān)產(chǎn)品信息